🇺🇸 FDA
Patent

US 8124592

Development of a preventive vaccine for filovirus infection in primates

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 8124592 (Development of a preventive vaccine for filovirus infection in primates) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K2039/545, A61K2039/55522